The FDA has responded to questions regarding cord blood licensure that were posed by HRSA at a meeting held in July.  These questions were compiled from those asked by representatives of cord blood banks at the NCBI All Bank Meeting held in DC at the end of March.  We hope you find the responses, which we’ve been cleared to share, helpful.

 FDA Responses to HRSA PDF Document